The publication of interim studies of the Sputnik V vaccine against the new coronavirus in The Lancet medical journal indicates global interest in the Russian drug, said Russian Health Minister Mikhail Murashko.
"Russians have the opportunity to be vaccinated against COVID-19 for free with one of the best vaccines, Sputnik V, from the Gamaleya Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia. Interim results of a post-registration clinical trial demonstrate its high efficacy and safety. And their publication in one of the world's leading peer-reviewed medical journals demonstrates both the highest quality of the study and the global interest in the Russian vaccine Sputnik V," he told reporters on Tuesday.
Earlier, The Lancet medical journal published the results of the third phase of a clinical trial of the Russian Sputnik V coronavirus vaccine, according to which the drug turned out to be one of the safest and most effective in the world. In particular, the effectiveness of the vaccine was 91.6% and 91.8% among volunteers over the age of 60. Antibodies to coronavirus after vaccination with Sputnik V were detected in 98% of volunteers. Cellular immunity was detected in all trial participants. Immunity after vaccination was 1.3-1.5 times higher than after the disease.
GSV "Russia - Islamic World"
Photo: Vitaly Nevar / TASS
Based on materials from TASS